Du är här

2017-05-23

Dignitana AB: DIGNITANA CONTINUES AUGMENTED GROWTH ACROSS THE U.S.

Scalp Cooling Technology for Women with Breast Cancer Available at 71
Medical Centers

Lund, Sweden - May 23, 2017-Dignitana AB, an international leader in
medical scalp-cooling technology and the manufacturer of the
DigniCap® scalp cooling system, announced today the availability of
the DigniCap® system in seven additional sites across the U.S.

The DigniCap® Scalp Cooling System was the first scalp cooling device
to complete rigorous FDA clinical trials and receive FDA clearance
for use by women with breast cancer undergoing chemotherapy. In the
pivotal trial seven out of ten patients with early-stage breast
cancer kept at least 50% of their hair. Results from Dignitana's
multi-center clinical trial were recently published in the
prestigious Journal of the American Medical Association
(http://jamanetwork.com/journals/jama/article-abstract/2601503)
(JAMA).

These seven new sites make DigniCap® accessible at a total of 71 U.S.
medical centers across 20 states. The following cancer treatment
centers are the most recent U.S. sites to include the DigniCap® scalp
cooling system as part of their breast cancer treatment and care
regimens:

· Mayo Clinic
(http://www.mayoclinic.org/patient-visitor-guide/arizona/clinic-hospital-...)

Phoenix, Arizona

· Michael Benjamin (http://doctormichaelbenjamin.com/)

West Hills, California

· Moffitt Cancer Center at International Plaza
(https://moffitt.org/locations-directions/moffitt-cancer-center-at-intern...)

Tampa, Florida

· NYU Langone Perlmutter Cancer Center
(http://nyulangone.org/locations/perlmutter-cancer-center)

New York, New York

· Pinellas Hematology Oncology
(http://www.pinellashematologyoncology.com/)

St. Petersburg, Florida

· South Carolina Oncology Associates
(https://sconcology.navigatingcare.com/)

Columbia, South Carolina

· Wellness Oncology (http://www.wellnessoncology.com/)

West Hills, California

"We are inspired by the feedback we have received from medical centers
across the U.S. and the demand for this revolutionary scalp cooling
treatment," said William Cronin, Chief Executive Officer of
Dignitana, Inc., the U.S. subsidiary of Dignitana AB. "We continue to
be humbled and honored to work with so many patient-focused medical
centers to make the DigniCap® scalp cooling system easily accessible
to breast cancer patients undergoing chemotherapy and offer this
extraordinary treatment option on a whole new scale."

The device features a patented tight-fitting silicone cooling cap that
is placed directly on the head, and an outer neoprene cap that
insulates and secures the silicone cap. The cooling cap is connected
to a cooling and control unit with touch screen prompts. A liquid
coolant circulates throughout the silicone cap, delivering consistent
and controlled cooling to all areas of the scalp. The cap is fitted
to the head, and the temperature of the scalp is lowered, resulting
in vasoconstriction with reduced delivery of chemotherapy to the
scalp, as well as reduced cellular uptake of drugs due to decreased
intra follicular metabolic rate. These factors together reduce the
risk of chemotherapy-induced hair loss.

This information is information that Dignitana AB is obliged to make
public pursuant to the EU Market Abuse Regulation. The information
was submitted for publication, by the above contact, for publication
at 14,30 (CET), May 23, 2017.

About Dignitana AB (publ)

Dignitana is a Swedish public company based in Lund and manufacturer
of the medical cooling device DigniCap®. Dignitana AB is listed on
Nasdaq First North Stockholm and has appointed Erik Penser Bank as
Certified Adviser. For more information visit www.dignitana.com

About The DigniCap® Scalp Cooling System

Dignitana's core product, DigniCap®, is a patented scalp-cooling
system that offers cancer patients the ability to keep their hair
during chemotherapy. DigniCap® provides continuous cooling with high
efficacy, safety and acceptable patient comfort.

###

Media Contacts:

Caren Browning Semmy Rülf

King + Company Chairman of the board, Dignitana AB

00 1 212 561-7464 +46 (0)709-312730

Caren.Browning@kingcompr.com semmy.rulf@dignitana.se

About Dignitana AB (publ)
Dignitana is a Swedish public company, based in Lund, and manufacturer
of the medical cooling device DigniCap®. Dignitana AB is listed on
Nasdaq First North Stockholm and has appointed Erik Penser Bank as
Certified Adviser. For more information visit www.dignitana.com

About the scalp cooling system DigniCap®
Dignitana's core product, DigniCap®, is a patented scalp-cooling
system that offers cancer patients the ability to keep their hair
during chemotherapy. DigniCap® provides continuous cooling with high
efficacy, safety and acceptable patient comfort.

-----------------------------------------------------------
http://news.cision.com/se/dignitana-ab/r/dignitana-continues-augmented-g...
http://mb.cision.com/Main/2116/2272446/678898.pdf

Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.